Interview with Emily Cheah, General Manager, BRASS
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Address: 33 Ubi Avenue 3,
#06-13/14 Vertex,
Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex,,Singapore
Tel: +65 6742 6007
Web: http://www.brass-asiapacific.com/c/
BRASS™ was conceived in the National University of Singapore (NUS) on May 1996 with the primary aim of supporting medical device development from concept into reality.
The brainchild of Assoc. Prof. Eugene Khor, BRASS™ is the answer to the biomedical industry’s need for vital infrastructure in support of the medical devices industry. BRASS™ was registered in December 1997 (hence “SINCE 1997”) and in April 1, 1999, the NUS incubation component of BRASS was granted permission to spin-off as a separate entity.
BRASS™ was awarded sole distributorship for the Charles River Endosafe brand of LAL Bacterial Endotoxin Test reagents in Singapore, Indonesia and Malaysia, an achievement that still remains to this day. With its growing success, BRASS™ was able to secure a partnership with the North American Science Associates, Inc. (NAMSA), the world leader in medical device safety evaluation, in July 2002. With this strategic alliance, BRASS™ is able to provide the full panel of GLP ISO 10993 biocompatibility testing, functional and performance studies, and material characterization to the medical device industry as well as gained the rights to distribute the full series of NAMSA Sterilization Assurance Products in several territories in the Asia Pacific region. In 2011, BRASS™ successfully attained representation for Charles River Biopharmaceutical Services in Singapore, Malaysia, Indonesia and Vietnam.
Thirteen years since its humble beginnings, BRASS™ has grown from strength to strength, and counts as its clients various multinational industry leaders, innovative start-ups and research institutes from the pharmaceutical and medical device industry in South East Asia.
Quality Product Provider: broad range of high quality and reliable media, packaging and sterilization assurance products.
Medical Device Expertise
Specialist in Microbiological Testing
Strategic and customized solutions for product development, regulatory compliance and quality assurance throughout the entire life-cycle of the medical device.
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical Technology Association (APACMed), shares how COVID has affected their business in the…
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the importance of leveraging learnings from the past year to create a more…
In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a chance to change the global narrative on medtech in healthcare,…
Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their proprietary technology to provide the world’s first stain-free AI-driven biopsy and tissue…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the company’s priorities in Malaysia, Singapore, and Brunei; and leveraging the Asian innovation ecosystem. …
The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences within it. Dr Philippi also outlines the impact of the…
Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation, its aggressive globalisation strategy over the last 15 years, the importance of the APAC region…
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is seeing an uptick in pharmaceutical manufacturing…
A roundup of some of the most significant healthcare and life science stories from across Singapore and the Asia-Pacific region, including the ongoing hunt for a COVID-19 vaccine and a…
Vishal Doshi, founder and CEO of AUM Biosciences, shares his motivation behind establishing the company and his mission to build an ecosystem within AUM for a decentralized biotech innovation model;…
Dr Charles Stacey, president and CEO of Brain Health company Cerecin, formerly Accera, discusses the rebrand, new investment, the company’s relocation to Asia, and the upcoming rollout of a global…
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.…
See our Cookie Privacy Policy Here
